81502582) and the Fundamental Research Funds for the Central Universities (N182004002)
Holzapfel C, Cresswell L, Ahern AL, Fuller NR, Eberhard M, Stoll J, et al
Routine clinical use of liraglutide 3 mg for the treatment of obesity: outcomes in non-surgical and bariatric surgery patients
It is widely believed that GLP-1s must be used indefinitely or the benefits will go away
Future Outlook: AI, Personalization, and Microdosing GLP-1s Artificial Intelligence (AI) and Machine Learning (ML) are quickly transforming modern medicine and helping to accelerate the move toward personalized dosing for medications like GLP-1 receptor agonists
And all of these other benefits from tip to toe that I mentioned in the body seem to be independent of weight loss and type 2 diabetes